Related Experiment Video

Updated: Jun 16, 2026

Quantitative Autoradiographic Method for Determination of Regional Rates of Cerebral Protein Synthesis In Vivo
11:01

Quantitative Autoradiographic Method for Determination of Regional Rates of Cerebral Protein Synthesis In Vivo

Published on: June 28, 2019

Pathogenesis of cognitive dysfunction in phenylketonuria: review of hypotheses

M J de Groot1, M Hoeksma, N Blau

  • 1Beatrix Children's Hospital, University Medical Center Groningen, Groningen, The Netherlands.

Molecular Genetics and Metabolism
|February 4, 2010
PubMed

Insights

Phenylketonuria (PKU) treatment improves cognition, but suboptimal outcomes persist. This review explores how high phenylalanine (Phe) impacts brain metabolism and function, focusing on amino acid transport and neurotransmitter synthesis.

Area of Science:

  • Biochemistry
  • Neuroscience
  • Genetics

Background:

  • Phenylketonuria (PKU) is a genetic disorder caused by phenylalanine hydroxylase (PAH) deficiency.
  • Elevated blood phenylalanine (Phe) in untreated PKU leads to severe intellectual disability.
  • Current dietary interventions improve cognitive outcomes but do not fully normalize them.

Purpose of the Study:

  • To review hypotheses regarding PKU pathogenesis.
  • To elucidate the mechanisms by which elevated Phe affects cerebral metabolism and cognitive function.
  • To focus on the impact of disturbed large neutral amino acid (LNAA) transport on brain function.

Main Methods:

  • Review of existing literature on PKU.
  • Analysis of hypotheses concerning Phe's effects on brain metabolism.
  • Examination of LNAA transport, neurotransmitter synthesis, and protein synthesis in PKU.

Main Results:

  • Elevated Phe concentrations disrupt LNAA transport into the brain.
  • Disrupted LNAA transport affects neurotransmitter and protein synthesis.
  • These disruptions are implicated in the cognitive deficits observed in PKU.

Conclusions:

  • The precise mechanisms linking elevated Phe to cognitive impairment are still under investigation.
  • Disturbed LNAA transport and its downstream effects on brain function are key areas of focus.
  • Understanding these mechanisms is crucial for improving clinical outcomes in PKU patients.

More Related Videos

A High-performance Liquid Chromatography Measurement of Kynurenine and Kynurenic Acid: Relating Biochemistry to Cognition and Sleep in Rats07:04

A High-performance Liquid Chromatography Measurement of Kynurenine and Kynurenic Acid: Relating Biochemistry to Cognition and Sleep in Rats

Published on: August 19, 2018

Studying Protein Function and the Role of Altered Protein Expression by Antibody Interference and Three-dimensional Reconstructions11:57

Studying Protein Function and the Role of Altered Protein Expression by Antibody Interference and Three-dimensional Reconstructions

Published on: April 21, 2016

Related Concept Videos

Inborn Errors of Metabolism01:20

Inborn Errors of Metabolism

Phenylketonuria (PKU) is a protein metabolism disorder characterized by high blood levels of the amino acid phenylalanine. This results from a mutation in the gene responsible for phenylalanine hydroxylase, an enzyme that converts phenylalanine into tyrosine. When this enzyme is deficient, phenylalanine builds up in the blood, leading to symptoms such as vomiting, rashes, seizures, growth deficiency, and severe mental retardation. An early diagnosis and a diet restricting phenylalanine intake...
Overview of Protein Metabolism01:21

Overview of Protein Metabolism

Proteins are broken down into amino acids during digestion. Unlike fats and carbohydrates, which are stored for later use, proteins are not. Instead, amino acids are either used to produce ATP through oxidation or contribute to the creation of new proteins for the growth and repair of the body. Any surplus amino acids from the diet are converted into glucose or triglycerides rather than excreted.
Amino acids play various roles in the body once they are absorbed into cells. They are restructured...
Hepatic Encephalopathy01:29

Hepatic Encephalopathy

DefinitionHepatic encephalopathy is a reversible neurologic syndrome that results from advanced liver dysfunction or portosystemic shunting. It leads to disturbances in cognition, behavior, and motor function due to the brain’s exposure to gut-derived toxins that the liver fails to detoxify.EtiologyThis condition develops either in the setting of acute fulminant hepatitis or progressively during chronic liver disease, such as cirrhosis and portal hypertension. Portosystemic shunting—including...
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...
Parkinson Disease ll: Pathophysiology01:24

Parkinson Disease ll: Pathophysiology

Parkinson disease (PD) is a progressive neurodegenerative disorder primarily affecting movement, with additional non-motor features. Its pathophysiology involves complex interactions among genetic susceptibility, environmental exposures, and cellular dysfunction, including dopaminergic neuron loss, protein aggregation, and mitochondrial impairment.Selective NeurodegenerationA key feature is the degeneration of dopaminergic neurons in the substantia nigra pars compacta, leading to reduced...
Psychosis: Pathophysiology of Schizophrenia and Other Psychotic Disorders01:27

Psychosis: Pathophysiology of Schizophrenia and Other Psychotic Disorders

Schizophrenia is a neurodevelopmental disorder whose origins are rooted in complex genetic components. Despite our burgeoning understanding, the pathophysiology of this disorder remains incompletely deciphered.
Researchers have identified genetic factors that increase susceptibility to schizophrenia, underscoring the intricate interplay between genetics and environment in disease development. At the core of schizophrenia's pathophysiology is excessive dopaminergic neurotransmission within the...